期刊文献+

乙型肝炎病毒感染与原发性肝癌相关的危险度分析 被引量:10

Risk analysis of hepatocellular carcinoma in people with hepatitis B virus infection
暂未订购
导出
摘要 目的:分析原发性肝癌(PHC)患者血清中乙型肝炎病毒(HBV)标志情况,探讨HBV感染与PHC危险性的关系。方法:收集在中国医科大学附属第一医院介入科住院的PHC患者224例作为病例组,同时期在此科住院的其他非肝病患者280例作为对照组,记录其血清HBV标志,与既往乙型肝炎和肝硬化等情况进行病例对照研究。结果:PHC组HBV总感染率为68.22%(146/214),以HBsAg阳性(65.42%,140/214)和抗-HBe阳性(30.84%,66/214)为主,对照组总感染率为7.63%(20/262),其中以HBsAg(3.44%,9/262)和抗-HBe(7.63%,20/262)为主。病例组感染率明显高于对照组(χ^2=200.1,P〈0.000 1),优势比OR=27.4(95%CI为16.0~46.9)。结论:HBV慢性感染是PHC的一个危险因素,在HBV慢性感染者中进行PHC筛查,对早期诊断PHC提高其临床疗效有重要意义。 OBJECTIVE: To study the relationship between hepatocellular carcinoma and hepatitis B virus by reviewing the level of serum markers of hepatitis B virus in hepatocellular carcinoma cases and other cases without liver diseases.METHODS:The cases of hepatocellular carcinoma(224) and non-liver diseases(280) were sampled hospitalized in the First Affiliated Hospital of China Medical University.Then a case-control study was performed on serum markers of HBV and the history of hepatitis B,cirrhosis and so on of all the cases.RESULTS: The total infection rate of HBV in the heatocellular carcinoma cases was 68.22%(146/214) with 65.42%(140/214) of HBsAg and 30.84%(66/214) of anti-HBe,and 7.63%(20/262) in the non-liver disease cases.There was a significant difference(χ^2=200.1,P〈0.000 1) on the total infection of HBV between the hepatocellular carcinoma cases and the controls,and the relative risk calculated was 27.4(95%CI 16.0-46.9).CONCLUSION: HBV is a major risk factor for hepatocellular carcinoma and PHC screening for people with HBV infection plays an important role in the PHC early diagnosis and improving therapeutic effect.
出处 《中华肿瘤防治杂志》 CAS 2008年第18期1368-1370,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 肝肿瘤 肝炎病毒 乙型 危险因素 liver neoplasms hepatitis B virus risk factor
  • 相关文献

参考文献10

  • 1Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA CancerJ Clin, 2005, 55(2):74-108.
  • 2Li L D, Lu F Z, Zhang S W, et al. Distribution analysis of cancer mortality in China during 1990- 1992 [J]. Chin J Oncol, 1996,18(6) :403-407.
  • 3Sun Z, Ming L, Zhu X, et al. Prevention and control of hepatitis B in China[J]. J Med Virol, 2002 ,67(3):447-450.
  • 4Wang L Y, You S L, Lu S N, et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male resident in Taiwan [J]. Cancer CauseControl, 2003,14 (3) : 241-250.
  • 5Zhu K, Moriarty C, Caplan L S. Cigarette smoking and primary liver cancer: a population-based case-control study in US men [J]. Cancer Causes Control,2007,18(3) :315-321.
  • 6Raza S A, Clifford G M, Franceschi S, Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review[J]. Br J Cancer, 2007, 96(7): 1127-1134.
  • 7Lavanchy D. Worldwide epidemiology of HBV infection,disease burden, and vaccine prevention[J]. J Clin Virol, 2005,34(Suppl 1) : S1-S3.
  • 8Bruix J, Llovet J M. Hepatitis B virus and hepetoeellular carcinoma[J]. J Hepatol,2003,39(Suppl 1): S59-S63.
  • 9袁萍,唐伟,文进,黎前明,罗华,粱伯衡,郑庆鸣,魏莉.中国四川和日本东京两地原发性肝癌手术患者肝炎病毒感染状况[J].中华预防医学杂志,2005,39(5):332-334. 被引量:22
  • 10袁萍,黎前明,罗华,文进,梁伯衡,魏莉.肝细胞癌手术患者的人口学和病毒学及临床特征研究[J].肿瘤防治杂志,2005,12(9):651-654. 被引量:1

二级参考文献30

  • 1沈靖,叶本法,徐耀初,沈洪兵,陈建国,张宝初,柳标,姜允辉,李文广,姚红玉,詹重厚,赵新民.烟、酒、茶等因素与肝癌关系的流行病学研究[J].中国慢性病预防与控制,1994,2(4):150-152. 被引量:8
  • 2龚晓红,王富珍,李辉,刘立荣,李阳桦,王宝兰,李立琴,张震,韩庆英,唐耀武.北京市儿童乙型肝炎疫苗接种12年后免疫效果观察[J].中华预防医学杂志,2005,39(4):265-268. 被引量:60
  • 3李国辉,李锦清,张亚奇,元云飞,陈敏山,郭荣平,林小军.600例肝切除术治疗肝癌的效果[J].中华肿瘤杂志,1995,17(2):125-128. 被引量:36
  • 4Kanematsu T, Furui J, Yanaga K, et al. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma:1985-2000[J]. Surgery, 2002,131(1 Suppl): 153158.
  • 5Yu M W, Chen C J. Hepatitis B and C viruses in the development of hepatocellular carcinoma[J]. Crit Rev Oncol Hematol,1994,17(2) :71-91.
  • 6London W T, McGlynn K A. Liver cancer[M]. New York: Oxford University Press, 1996. 772-793.
  • 7徐光炜.(Martin D.Abeloff,James O.Armitage,Allen S.Lichter,John E. Niederhuber,原著).临床肿瘤学[M].下卷.沈阳:辽宁教育出版社,1999.1270.
  • 8Taketa K. α-fetoprotein: Reevaluation in hepatology[J]. Hepatology, 1990, 12(6): 1420- 1432.
  • 9Cui R, Wang B, Ding H, et al. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma[J]. Chin Med J (Engl), 2002,115(1) :42-45.
  • 10Kaczynski J, Oden A, Watson R. W, et al. The Rising Incidence of Hepatocellular Carcinoma[J]. N Engl J Med, 1999,341(6): 451-452.

共引文献21

同被引文献88

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部